Year |
Citation |
Score |
2023 |
Hanson J, Groff D, Carlos A, Usman H, Fong K, Yu A, Armstrong S, Dwyer A, Masikat MR, Yuan D, Tran C, Heibeck T, Zawada J, Chen R, Hallam T, et al. An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates. Bioengineering (Basel, Switzerland). 10. PMID 36978695 DOI: 10.3390/bioengineering10030304 |
0.437 |
|
2022 |
Zawada JF, Burgenson D, Yin G, Hallam TJ, Swartz JR, Kiss RD. Cell-free technologies for biopharmaceutical research and production. Current Opinion in Biotechnology. 76: 102719. PMID 35569340 DOI: 10.1016/j.copbio.2022.102719 |
0.522 |
|
2019 |
Abrahams C, Krimm S, Li X, Zhou S, Hanson J, Masikat MR, Bajjuri K, Heibeck T, Kothari D, Yu A, Henningsen R, Tran C, Yin G, Zawada J, Hang J, et al. Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Nt-090 |
0.363 |
|
2018 |
Solis W, Almeida VD, Yu A, Bruhns M, Zawada J, Galan A, Matheny S, Molina A, Hallam T, Lupher M. Abstract 742: Nonclinical safety evaluation of STRO-001, a site-specific anti-CD74 antibody-drug conjugate for the potential treatment of B-cell malignancies Cancer Research. 78: 742-742. DOI: 10.1158/1538-7445.Am2018-742 |
0.368 |
|
2018 |
Li X, Abrahams C, Zhou S, Krimm S, Henningsen R, Stephenson H, Hanson J, Masikat MR, Bajjuri K, Heibeck T, Tran C, Yin G, Zawada J, Sarma G, Chen J, et al. Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer Cancer Research. 78: 1782-1782. DOI: 10.1158/1538-7445.Am2018-1782 |
0.367 |
|
2017 |
Abrahams C, Li X, DeAlmeida V, Embry M, Yu A, Krim S, Hoffmann H, Zawada J, Bruhns M, Matheny S, Bussell S, Kline T, Yam A, Stafford R, Hallam T, et al. Abstract 67: Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies Cancer Research. 77: 67-67. DOI: 10.1158/1538-7445.Am2017-67 |
0.406 |
|
2016 |
Li X, Abrahams C, Embry M, Yu A, Kahana J, Brown M, Narla RK, Barnes L, Schwartz E, Boylan J, Zawada J, Stephenson H, Bruhns M, Bussell S, Steiner A, et al. Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL) Blood. 128: 464-464. DOI: 10.1182/Blood.V128.22.464.464 |
0.364 |
|
2016 |
Abrahams C, Li X, Yu A, Krimm S, Kahana J, Narla RK, Schwartz E, Boylan J, Hoffmann H, Steiner A, Zawada J, Stephenson H, Bruhns M, DeAlmeida V, Matheny S, et al. Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models Blood. 128: 4465-4465. DOI: 10.1182/Blood.V128.22.4465.4465 |
0.393 |
|
2015 |
Cai Q, Hanson JA, Steiner AR, Tran C, Masikat MR, Chen R, Zawada JF, Sato AK, Hallam TJ, Yin G. A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems. Biotechnology Progress. 31: 823-31. PMID 25826247 DOI: 10.1002/Btpr.2082 |
0.496 |
|
2012 |
Yin G, Garces ED, Yang J, Zhang J, Tran C, Steiner AR, Roos C, Bajad S, Hudak S, Penta K, Zawada J, Pollitt S, Murray CJ. Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. Mabs. 4: 217-25. PMID 22377750 DOI: 10.4161/Mabs.4.2.19202 |
0.372 |
|
2012 |
Zawada JF. Preparation and testing of E. coli S30 in vitro transcription translation extracts. Methods in Molecular Biology (Clifton, N.J.). 805: 31-41. PMID 22094798 DOI: 10.1007/978-1-61779-379-0_2 |
0.357 |
|
2011 |
Zawada JF, Yin G, Steiner AR, Yang J, Naresh A, Roy SM, Gold DS, Heinsohn HG, Murray CJ. Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines. Biotechnology and Bioengineering. 108: 1570-8. PMID 21337337 DOI: 10.1002/Bit.23103 |
0.508 |
|
2006 |
Zawada J, Swartz J. Effects of growth rate on cell extract performance in cell-free protein synthesis. Biotechnology and Bioengineering. 94: 618-24. PMID 16673418 DOI: 10.1002/Bit.20831 |
0.591 |
|
2005 |
Liu DV, Zawada JF, Swartz JR. Streamlining Escherichia coli S30 extract preparation for economical cell-free protein synthesis. Biotechnology Progress. 21: 460-5. PMID 15801786 DOI: 10.1021/Bp049789Y |
0.569 |
|
2005 |
Zawada J, Swartz J. Maintaining rapid growth in moderate-density Escherichia coli fermentations. Biotechnology and Bioengineering. 89: 407-15. PMID 15635610 DOI: 10.1002/Bit.20369 |
0.564 |
|
Show low-probability matches. |